JWM
VRTX icon

JPL Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

JPL Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.6K Buy
+122
New +$56.9K 0.01% 225
2025
Q4 		– Sell
-128
Closed -$50.2K – 1104
2025
Q3 		$50.2K Buy
+128
New +$53.5K 0.01% 249

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JPL Wealth Management's VRTX Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 122 shares worth $54.6K. The stake represents 0.01% of the portfolio and ranks #225 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in VRTX as recently as Q3 2025.

JPL Wealth Management first reported a position in VRTX in Q3 2025 and has held it in 2 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • JPL Wealth Management held 122 shares of Vertex Pharmaceuticals worth $54.6K as of Q1 2026.
  • Vertex Pharmaceuticals was a new JPL Wealth Management position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of JPL Wealth Management's portfolio in Q1 2026, its #225 holding.
  • JPL Wealth Management first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.